Maxime Dougados

11.4k total citations · 3 hit papers
59 papers, 6.5k citations indexed

About

Maxime Dougados is a scholar working on Rheumatology, Surgery and Pharmacology. According to data from OpenAlex, Maxime Dougados has authored 59 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Rheumatology, 17 papers in Surgery and 16 papers in Pharmacology. Recurrent topics in Maxime Dougados's work include Osteoarthritis Treatment and Mechanisms (32 papers), Rheumatoid Arthritis Research and Therapies (20 papers) and Musculoskeletal pain and rehabilitation (8 papers). Maxime Dougados is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (32 papers), Rheumatoid Arthritis Research and Therapies (20 papers) and Musculoskeletal pain and rehabilitation (8 papers). Maxime Dougados collaborates with scholars based in France, United Kingdom and United States. Maxime Dougados's co-authors include Stefan Lohmander, Marc C. Hochberg, Roy D. Altman, Peter Tugwell, Michael Doherty, K. Kwoh, K D Brandt, David J. Hunter, Weiya Zhang and Peter Croft and has published in prestigious journals such as Journal of Clinical Epidemiology, Annals of the Rheumatic Diseases and Drugs.

In The Last Decade

Maxime Dougados

55 papers receiving 6.2k citations

Hit Papers

OARSI recommendations for... 2007 2026 2013 2019 2008 2010 2007 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxime Dougados France 25 4.6k 2.6k 2.2k 781 579 59 6.5k
Stephan Reichenbach Switzerland 45 3.7k 0.8× 2.7k 1.1× 2.5k 1.1× 551 0.7× 905 1.6× 96 8.6k
K. Kwoh United States 20 5.1k 1.1× 3.0k 1.1× 2.4k 1.1× 1.2k 1.5× 791 1.4× 41 7.4k
Ilana N. Ackerman Australia 32 2.8k 0.6× 3.0k 1.1× 1.1k 0.5× 636 0.8× 754 1.3× 148 5.7k
Marlene Fransen Australia 20 2.7k 0.6× 1.9k 0.7× 1.2k 0.5× 695 0.9× 430 0.7× 29 4.6k
François Rannou France 34 2.8k 0.6× 1.7k 0.6× 1.4k 0.6× 427 0.5× 440 0.8× 112 4.5k
Jane Campbell Canada 11 4.1k 0.9× 4.9k 1.9× 1.9k 0.9× 1.2k 1.5× 961 1.7× 13 8.2k
W. Watson Buchanan Canada 21 4.0k 0.9× 4.5k 1.7× 1.8k 0.8× 1.2k 1.5× 737 1.3× 82 8.4k
T.E. McAlindon United States 17 4.1k 0.9× 2.4k 0.9× 1.5k 0.7× 1.3k 1.6× 699 1.2× 45 5.7k
K D Brandt United States 35 6.6k 1.5× 4.1k 1.6× 2.5k 1.2× 1.7k 2.1× 1.3k 2.2× 96 9.4k
Piran Aliabadi United States 42 4.7k 1.0× 4.1k 1.6× 1.0k 0.5× 1.7k 2.2× 975 1.7× 80 7.1k

Countries citing papers authored by Maxime Dougados

Since Specialization
Citations

This map shows the geographic impact of Maxime Dougados's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Dougados with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Dougados more than expected).

Fields of papers citing papers by Maxime Dougados

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Dougados. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Dougados. The network helps show where Maxime Dougados may publish in the future.

Co-authorship network of co-authors of Maxime Dougados

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Dougados. A scholar is included among the top collaborators of Maxime Dougados based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Dougados. Maxime Dougados is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Busse, Jason W., Susan J. Bartlett, Maxime Dougados, et al.. (2015). Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop. The Journal of Rheumatology. 42(10). 1962–1970. 115 indexed citations
2.
Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2012). Clinical, Radiographic, and Immunogenic Effects After 1 Year of Tocilizumab-Based Treatment Strategy with and without Methotrexate in Rheumatoid Arthritis: The ACT-RAY Study. Data Archiving and Networked Services (DANS). 64(10). 6 indexed citations
3.
Dougados, Maxime, K. Kissel, Howard Amital, et al.. (2011). Double-Blind Study of Tocilizumab Plus Methotrexate Vs Tocilizumab Plus Placebo in Patients with Active Rheumatoid Arthritis Despite Prior Methotrexate : Progression of Structural Damage, Quality of Life, and Physical Function At 24 Weeks.. Data Archiving and Networked Services (DANS). 63(10). 28–29. 6 indexed citations
4.
Strand, Vibeke, Lee S. Simon, Maxime Dougados, et al.. (2011). Treatment of Osteoarthritis with Continuous Versus Intermittent Celecoxib. The Journal of Rheumatology. 38(12). 2625–2634. 20 indexed citations
5.
Zhang, Weiya, G. Nuki, Roland W. Moskowitz, et al.. (2010). OARSI recommendations for the management of hip and knee osteoarthritis. Osteoarthritis and Cartilage. 18(4). 476–499. 1253 indexed citations breakdown →
7.
Wells, George A., et al.. (2009). Achievement of sustained low disease activity state predicts the absence of structural damage progression in patients with Rheumatoid arthritis: insights from the abatacept database.. The Journal of Rheumatology. 26. 2593–2594. 1 indexed citations
8.
Ornetti, Paul, K D Brandt, Marc C. Hochberg, et al.. (2009). OARSI–OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis and Cartilage. 17(7). 856–863. 89 indexed citations
9.
Zhang, Weiya, Roland W. Moskowitz, G. Nuki, et al.. (2008). OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage. 16(2). 137–162. 2135 indexed citations breakdown →
10.
Davis, Aileen M., Anthony V. Perruccio, Mayilée Cañizares, et al.. (2008). The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative. Osteoarthritis and Cartilage. 16(5). 551–559. 152 indexed citations
11.
Botha-Scheepers, S., Maxime Dougados, Philippe Ravaud, et al.. (2008). Effect of medial tibial plateau alignment on serial radiographs on the capacity to predict progression of knee osteoarthritis. Osteoarthritis and Cartilage. 16(2). 272–276. 11 indexed citations
12.
Perruccio, Anthony V., Stefan Lohmander, Mayilée Cañizares, et al.. (2008). The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) – an OARSI/OMERACT initiative. Osteoarthritis and Cartilage. 16(5). 542–550. 262 indexed citations
13.
Botha-Scheepers, S., M. Kloppenburg, Herman M. Kroon, et al.. (2006). Fixed-flexion knee radiography: the sensitivity to detect knee joint space narrowing in osteoarthritis. Osteoarthritis and Cartilage. 15(3). 350–353. 28 indexed citations
14.
Cline, Gary A., S. Adámi, C. Buckland-Wright, et al.. (2004). Predictors of structural progression in knee osteoarthritis over 24 months. Osteoarthritis and Cartilage. 12. 4 indexed citations
15.
Auleley, Guy‐Robert, Bruno Giraudeau, Gabriel Baron, et al.. (2004). The methods for handling missing data in clinical trials influence sample size requirements. Journal of Clinical Epidemiology. 57(5). 447–453. 20 indexed citations
16.
Dougados, Maxime. (2004). Osteoarthritis. 2nd ed. Annals of the Rheumatic Diseases. 63(3). 328–328. 32 indexed citations
17.
Pham, Thao, Désirée van der Heijde, Marissa Lassere, et al.. (2003). Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria.. PubMed. 30(7). 1648–54. 217 indexed citations
18.
Pham, Tri Nhut, D. van der Heijde, Nicholas Bellamy, et al.. (2002). OMERACT-OARSI Initiative: OARSI set of responder criteria for osteoarthritis (OA) clinical trials revisited. Queensland's institutional digital repository (The University of Queensland). 10. 1 indexed citations
19.
Dougados, Maxime. (1997). Diacerein. Drugs. 53(1). 107–108. 1 indexed citations
20.
Dougados, Maxime, M Tulliez, André Kahan, et al.. (1987). Iléocolonoscopie systématique au cours des spondyloarthropathies séronégatives.. 54(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026